What is the Return on Assets (ROA) of Haemato this year?
The Return on Assets (ROA) of Haemato is 0.05 undefined this year.
Haemato ROA 2024
Haemato ROA
0.05
Haemato Dividend yield
6.4 %
Ticker
HAEK.HM
ISIN
DE000A289VV1
WKN
A289VV
In 2024, Haemato's return on assets (ROA) was 0.05, a 29.92% increase from the 0.04 ROA in the previous year.
Haemato Aktienanalyse
What does Haemato do?
Haemato AG is a German company specializing in the trade of high-quality pharmaceuticals and medical products. It was founded in 1993 and has become one of the leading companies in this field. The company's goal is to offer quality medications and medical products for the German market. They carefully select products and collaborate with renowned manufacturers and suppliers to ensure success. Haemato AG is divided into different divisions specializing in the trade of various pharmaceuticals and medical products for oncology, pain therapy, rheumatology, and dermatology. They collaborate with Pfizer, Roche, and Merck for oncology medications. For pain therapy, they offer a range of products including pain relievers and specialized therapies. In rheumatology, they focus on diseases of the musculoskeletal system such as osteoporosis and arthritis. They provide a wide range of medications and medical products tailored to these diseases. In dermatology, they specialize in treating skin conditions such as psoriasis and eczema, offering a variety of medications and medical products. They also offer other products including medical devices like injection needles, syringes, EKG machines, and ultrasound devices. Their business model is based on close collaboration with leading manufacturers and suppliers to ensure high-quality products. They also prioritize comprehensive consultation and support for their customers to ensure they receive the right products for their specific needs. In summary, Haemato AG is a leading company in the pharmaceutical and medical product trade, offering a wide range of products and collaborating with top manufacturers and suppliers to provide high-quality and comprehensive solutions for medical needs. Haemato ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Haemato's Return on Assets (ROA)
Haemato's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Haemato's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Haemato's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Haemato’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Haemato Stock
What was the ROA of Haemato compared to the previous year?
The ROA of Haemato has increased by 29.92% compared to the previous year.
What consequences do high ROA have for investors of Haemato?
A high ROA is advantageous for investors of Haemato, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Haemato?
A low ROA can be unfavorable for investors of Haemato as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Haemato affect the company?
An increase in ROA of Haemato can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Haemato impact the company?
A reduction in the ROA of Haemato can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Haemato?
Some factors that can influence the ROA of Haemato include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Haemato important for investors?
The ROA of Haemato is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Haemato take to improve ROA?
To improve ROA, Haemato can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Haemato pay?
Over the past 12 months, Haemato paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 6.4 %. For the coming 12 months, Haemato is expected to pay a dividend of 1.12 EUR.
What is the dividend yield of Haemato?
The current dividend yield of Haemato is 6.4 %.
When does Haemato pay dividends?
Haemato pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Haemato?
Haemato paid dividends every year for the past 0 years.
What is the dividend of Haemato?
For the upcoming 12 months, dividends amounting to 1.12 EUR are expected. This corresponds to a dividend yield of 6.49 %.
In which sector is Haemato located?
Haemato is assigned to the 'Health' sector.
Wann musste ich die Aktien von Haemato kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Haemato from 7/21/2023 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 7/19/2023.
When did Haemato pay the last dividend?
The last dividend was paid out on 7/21/2023.
What was the dividend of Haemato in the year 2023?
In the year 2023, Haemato distributed 1.1 EUR as dividends.
In which currency does Haemato pay out the dividend?
The dividends of Haemato are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Haemato
Our stock analysis for Haemato Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haemato Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.